Northstar’s Board Denies Tang Capital’s Offer
| July 8th, 2008 | ||
| Northstar Neuroscience (NASDAQ: NSTR), a medical device company, announced today that it was not interested in negotiating with Tang Capital Partners. The press release stated that the “Board of Directors has reviewed the proposal from Tang Capital Partners to enter into negotiations to acquire Northstar for $2.25 per share and concluded that the proposal is not in the best interests of all shareholders. Management and the Board of Directors will continue to work with the Company's financial advisor, Leerink Swann, to evaluate strategic alternatives.” | ||
For Detailed Investor Profiles on these Investors, click below: |
Tang Capital Management |
Related People: Kevin C. Tang
Related Entities: Aclara Biosciences Inc;
Related Article Tags: Shareholder Activists, Corporate Raiders and Proxy Battles
Add a Comment |
More Recent Headlines
GLG recruits Driss Ben-Brahim from Goldman |
Icahn's Hedge Funds post losses |
Scotia doubts Obrem demands for MDS shakeup |
Tang Capital Makes Takeover Bid for Northstar Neuroscience |
Hedge Funds Claim Victory in CSX Proxy Vote |
Dissident Investors unsuccessful in Japan |
Kerkorian to invest in Ford |
Hedge funds from former Lehman managers buying up assets |
Tightening of Capital Markets hurt Smaller Hedge Funds |
Tudor Investment Corporation hires Bear Vets to Create Distressed-Debt Strategy |
